Enertopia Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Enertopia Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Aug 31, 2014 | $0 | Dec 1, 2014 |
| FY2014 | Aug 31, 2013 | $0 | Dec 1, 2014 |
| FY2013 | Aug 31, 2012 | $0 | Dec 6, 2013 |
| FY2012 | Aug 31, 2011 | $20.5K | Nov 29, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Aug 31, 2017 | $0 | Nov 14, 2017 |
| FY2017 | Aug 31, 2016 | $6.0K | Nov 14, 2017 |
| FY2016 | Aug 31, 2015 | $4.8K | Nov 29, 2016 |
| FY2014 | Aug 31, 2014 | $0 | Dec 1, 2014 |
| FY2014 | Aug 31, 2013 | $0 | Dec 1, 2014 |
| FY2013 | Aug 31, 2012 | ($310) | Dec 6, 2013 |
| FY2012 | Aug 31, 2011 | $5.7K | Nov 29, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | ($506.9K) | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | ($999.0K) | Dec 16, 2025 |
| FY2022 | Aug 31, 2022 | $1.97M | Nov 29, 2022 |
| FY2022 | Aug 31, 2021 | ($389.4K) | Nov 29, 2022 |
| FY2021 | Aug 31, 2020 | $34.1K | Nov 10, 2021 |
| FY2020 | Aug 31, 2019 | ($422.3K) | Nov 4, 2020 |
| FY2019 | Aug 31, 2018 | ($650.1K) | Nov 27, 2019 |
| FY2018 | Aug 31, 2017 | ($801.2K) | Nov 21, 2018 |
| FY2017 | Aug 31, 2016 | ($525.5K) | Nov 14, 2017 |
| FY2016 | Aug 31, 2015 | ($1.15M) | Nov 29, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | ($513.7K) | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | ($665.6K) | Dec 16, 2025 |
| FY2024 | Aug 31, 2023 | ($1.22M) | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | ($1.57M) | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | ($614.8K) | Nov 29, 2022 |
| FY2021 | Aug 31, 2020 | ($170.1K) | Nov 10, 2021 |
| FY2020 | Aug 31, 2019 | ($419.0K) | Nov 4, 2020 |
| FY2019 | Aug 31, 2018 | ($637.8K) | Nov 27, 2019 |
| FY2018 | Aug 31, 2017 | ($726.9K) | Nov 21, 2018 |
| FY2017 | Aug 31, 2016 | ($464.4K) | Nov 14, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $153.3K | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | $156.7K | Dec 16, 2025 |
| FY2024 | Aug 31, 2023 | $156.6K | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | $808.8K | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | $12.6K | Nov 29, 2022 |
| FY2021 | Aug 31, 2020 | $1.7K | Nov 10, 2021 |
| FY2020 | Aug 31, 2019 | $14.7K | Nov 4, 2020 |
| FY2019 | Aug 31, 2018 | $230.6K | Nov 27, 2019 |
| FY2018 | Aug 31, 2017 | $20.8K | Nov 21, 2018 |
| FY2017 | Aug 31, 2016 | $4.6K | Nov 14, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | ($407.0K) | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | ($665.8K) | Dec 16, 2025 |
| FY2024 | Aug 31, 2023 | ($1.21M) | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | ($970.0K) | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | ($408.2K) | Nov 29, 2022 |
| FY2021 | Aug 31, 2020 | ($127.1K) | Nov 10, 2021 |
| FY2020 | Aug 31, 2019 | ($326.0K) | Nov 4, 2020 |
| FY2019 | Aug 31, 2018 | ($594.9K) | Nov 27, 2019 |
| FY2018 | Aug 31, 2017 | ($370.3K) | Nov 21, 2018 |
| FY2017 | Aug 31, 2016 | ($384.3K) | Nov 14, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Aug 31, 2018 | $0 | Nov 21, 2018 |
| FY2018 | Aug 31, 2017 | $5.0K | Nov 21, 2018 |
| FY2017 | Aug 31, 2016 | $19.0K | Nov 14, 2017 |
| FY2016 | Aug 31, 2015 | $0 | Nov 29, 2016 |
| FY2014 | Aug 31, 2014 | $0 | Dec 1, 2014 |
| FY2014 | Aug 31, 2013 | $40.0K | Dec 1, 2014 |
| FY2013 | Aug 31, 2012 | $104.8K | Dec 6, 2013 |
| FY2012 | Aug 31, 2011 | $87.0K | Nov 29, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $125.5K | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | $342.6K | Dec 16, 2025 |
| FY2024 | Aug 31, 2023 | $1.36M | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | $3.21M | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | $415.1K | Nov 29, 2022 |
| FY2021 | Aug 31, 2020 | $86.2K | Nov 10, 2021 |
| FY2020 | Aug 31, 2019 | $46.2K | Nov 4, 2020 |
| FY2019 | Aug 31, 2018 | $271.7K | Nov 27, 2019 |
| FY2018 | Aug 31, 2017 | $191.2K | Nov 21, 2018 |
| FY2017 | Aug 31, 2016 | $240.4K | Nov 14, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Aug 31, 2024 | $316.0K | Nov 25, 2024 |
| FY2024 | Aug 31, 2023 | $332.6K | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | $357.9K | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | $420.9K | Nov 29, 2022 |
| FY2021 | Aug 31, 2020 | $479.2K | Nov 10, 2021 |
| FY2020 | Aug 31, 2019 | $502.1K | Nov 4, 2020 |
| FY2019 | Aug 31, 2018 | $449.3K | Nov 27, 2019 |
| FY2013 | Aug 31, 2013 | $525.9K | Dec 6, 2013 |
| FY2013 | Aug 31, 2012 | $374.4K | Dec 6, 2013 |
| FY2012 | Aug 31, 2011 | $389.5K | Nov 29, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | ($198.3K) | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | $27.8K | Dec 16, 2025 |
| FY2024 | Aug 31, 2023 | $1.03M | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | $2.86M | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | ($5.8K) | Nov 29, 2022 |
| FY2022 | Aug 31, 2020 | ($393.0K) | Nov 29, 2022 |
| FY2021 | Aug 31, 2019 | ($455.9K) | Nov 10, 2021 |
| FY2020 | Aug 31, 2018 | ($177.6K) | Nov 4, 2020 |
| FY2019 | Aug 31, 2017 | ($237.5K) | Nov 27, 2019 |
| FY2018 | Aug 31, 2016 | ($136.1K) | Nov 21, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | ($16.03M) | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | ($15.52M) | Dec 16, 2025 |
| FY2024 | Aug 31, 2023 | ($14.53M) | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | ($12.69M) | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | ($14.67M) | Nov 29, 2022 |
| FY2021 | Aug 31, 2020 | ($14.28M) | Nov 10, 2021 |
| FY2020 | Aug 31, 2019 | ($14.31M) | Nov 4, 2020 |
| FY2019 | Aug 31, 2018 | ($13.89M) | Nov 27, 2019 |
| FY2016 | Aug 31, 2016 | $0 | Nov 29, 2016 |
| FY2016 | Aug 31, 2015 | $0 | Nov 29, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $74.7K | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | $179.9K | Dec 16, 2025 |
| FY2024 | Aug 31, 2023 | $259.6K | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | $615.2K | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | $354.3K | Nov 29, 2022 |
| FY2021 | Aug 31, 2020 | $45.5K | Nov 10, 2021 |
| FY2021 | Aug 31, 2019 | $9.8K | Nov 10, 2021 |
| FY2020 | Aug 31, 2018 | $176.4K | Nov 4, 2020 |
| FY2019 | Aug 31, 2017 | $150.9K | Nov 27, 2019 |
| FY2018 | Aug 31, 2016 | $31.0K | Nov 21, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 0 | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | 0 | Dec 16, 2025 |
| FY2024 | Aug 31, 2023 | 0 | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | 0 | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | 0 | Nov 29, 2022 |
| FY2013 | Aug 31, 2013 | 0 | Dec 6, 2013 |
| FY2013 | Aug 31, 2012 | 0 | Dec 6, 2013 |
| FY2012 | Aug 31, 2011 | 0 | Nov 29, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 0 | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | 0 | Dec 16, 2025 |
| FY2024 | Aug 31, 2023 | 0 | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | 0 | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | 0 | Nov 29, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 10.34M | Dec 16, 2025 |
| FY2025 | Aug 31, 2024 | 7.76M | Dec 16, 2025 |
| FY2024 | Aug 31, 2023 | 155.17M | Nov 25, 2024 |
| FY2023 | Aug 31, 2022 | 155.12M | Mar 18, 2024 |
| FY2022 | Aug 31, 2021 | 139.21M | Nov 29, 2022 |
| FY2021 | Aug 31, 2020 | 128.47M | Nov 10, 2021 |
| FY2020 | Aug 31, 2019 | 127.47M | Nov 4, 2020 |
| FY2019 | Aug 31, 2018 | 119.74M | Nov 27, 2019 |
| FY2018 | Aug 31, 2017 | 102.30M | Nov 21, 2018 |
| FY2017 | Aug 31, 2016 | 89.53M | Nov 14, 2017 |